A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% ...

Chronic obstructive pulmonary disease (COPD) is known for causing breathing difficulties and limiting everyday activities. Obstructive sleep apnea syndrome (OSAS), on the other hand, is usually ...

Millions of people in the U.S. have sleep apnea, most of whom aren’t getting treated for it. But a simple daily pill of an ...

A new solution may be on the horizon for the 30 million people in the U.S. who suffer from sleep apnea. In a Finland study, a new breathing device showed promising results in reducing symptoms of the ...

Doctors regularly advise patients on better sleep hygiene, yet many struggle to get enough rest themselves. On World Sleep ...

Obstructive sleep apnea (OSA) is a common sleep disorder characterized by oxygen desaturation due to repeated airway collapse ...

Upadacitinib may improve self-reported sleep quality at 3 months in patients with rheumatoid arthritis, with sustained benefits seen over the long term.